United States:
Analysis Of Medicare, Medicaid, And Other Health Policy Provisions In Bipartisan Budget Act
27 February 2018
Reed Smith
To print this article, all you need is to be registered or login on Mondaq.com.
The newly-enacted Bipartisan Budget Act of 2018 includes
numerous Medicare, Medicaid, and other policy and payment
provisions impacting health providers and manufacturers. Of
particular note, the new law: increases Medicaid rebate
obligations with respect to line extension drugs; changes
manufacturer discount obligations in the Medicare Part D
"donut hole"; repeals the Independent Payment Advisory
Board (IPAB); makes Stark Act revisions; and significantly
increases penalties for violations of various anti-fraud
statutes. A Reed Smith Client Alert focusing on the major
Medicare, Medicaid, and public health provisions of the Act is
available
here (download attachment link shown).
This article is presented for informational purposes only
and is not intended to constitute legal advice.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Healthcare Policy Developments To Watch In 2024
Crowell & Moring LLP
The ever-changing healthcare policy landscape will witness at the federal level regulatory changes driven by the need to transform healthcare delivery, quality and innovation.
The FDA And The Future Of AI Oversight
Manatt, Phelps & Phillips LLP
In January 2024, the U.S. Government Accountability Office (GAO) issued a report highlighting current obstacles to the U.S. Food and Drug Administration's (FDA) timely and effective regulation...